Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Baxter Expands Biologics Capacity | Contract Pharma

What are you searching for?

Sign in
Breaking News

Baxter Expands Biologics Capacity

Billion-dollar site to support plasma-based treatments

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Baxter International will build a new state-of-the-art manufacturing facility in Georgia to support growth of its plasma-based treatments. These therapies include treatments for immune disorders, trauma and other critical conditions. Baxter expects capital investments at the Covington, Ga., site to exceed $1 billion during the next five years and to result in the creation of more than 1,500 full-time positions in Georgia and more than 2,000 jobs in total across multiple U.S. locations.

”This investment demonstrates our long-term commitment to patients around the world who rely on our plasma-based therapies,” said Robert L. Parkinson, Jr., Baxter’s chairman and chief executive officer.

Construction will begin this year at the new site, which will include operations supporting plasma fractionation, purification, fill-finish and a testing lab. Commercial production is scheduled to begin in 2018, with the new plasma fractionation facility adding up to three million liters of new capacity annually when fully operational. The site will have the flexibility and necessary infrastructure to expand further to support additional global market needs.

In connection with this investment, the company also expects to create more than two hundred new positions in Illinois, including jobs associated with expanded filling and finishing capacity at its existing manufacturing facility in Round Lake, IL. The new jobs at the Round Lake facility will support production of Flexbumin, a preparation of plasma-based albumin treatment in a flexible container.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics